Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation TCT 2021

Case Presentation 1 Case: Vulnerable Stenosis by CTA, but FFR Negative or Borderline (From Dr. Koo); Vulnerable Stenosis by OCT/IVUS/NIRS/s Ischemia (From Dr. Erlinge)

Presenter: Jeehoon Kang

November 06, 2021

Presentation TCT 2021

FFR REACT: A Randomized Trial of FFR-Guided PCI Optimization by IVUS Versus No Optimization

Presenter: Joost Daemen

November 05, 2021

Presentation TCT 2021

Case 1: Provisional With One Stent – Does FFR Help Us?

Presenter: Bon-Kwon Koo

November 04, 2021

Presentation TCT 2021

iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI

Presenter: Matthias Götberg

November 04, 2021

News Conference News TCT 2021

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

Caitlin E. Cox

November 04, 2021

News Conference News TCT 2021

FAVOR III China Adds Strength to Value of QFR-Guided PCI

L.A. McKeown

November 04, 2021

News Conference News TCT 2021

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Michael O'Riordan

November 04, 2021

Presentation TCT 2021

FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG

Presenter: William Fearon

November 04, 2021

Presentation TCT 2021

TCT 82: Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events: Insights From the COMBINE FFR-OCT Trial

Presenter: Wojciech Wojakowski

November 04, 2021

Video

» Interview

FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG

November 4, 2021

Video

» Interview

FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG

November 7, 2021

Advertisement

Case Presentation 1 Case: Vulnerable Stenosis by CTA, but FFR Negative or Borderline (From Dr. Koo); Vulnerable Stenosis by OCT/IVUS/NIRS/s Ischemia (From Dr. Erlinge)

FFR REACT: A Randomized Trial of FFR-Guided PCI Optimization by IVUS Versus No Optimization

Case 1: Provisional With One Stent – Does FFR Help Us?

iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

FAVOR III China Adds Strength to Value of QFR-Guided PCI

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG

TCT 82: Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events: Insights From the COMBINE FFR-OCT Trial

FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG

FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content